Spero Therapeutics Stock Price Prediction
| SPRO Stock | USD 2.44 0.01 0.41% |
Momentum 66
Buy Stretched
Oversold | Overbought |
Quarterly Earnings Growth 0.753 | EPS Estimate Next Quarter (0.22) | EPS Estimate Current Year (0.10) | EPS Estimate Next Year 0.67 | Wall Street Target Price 4 |
Using Spero Therapeutics hype-based prediction, you can estimate the value of Spero Therapeutics from the perspective of Spero Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Spero Therapeutics using Spero Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Spero using crowd psychology based on the activity and movement of Spero Therapeutics' stock price.
Spero Therapeutics Implied Volatility | 1.72 |
Spero Therapeutics' implied volatility exposes the market's sentiment of Spero Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Spero Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Spero Therapeutics stock will not fluctuate a lot when Spero Therapeutics' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Spero Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Spero because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Spero Therapeutics after-hype prediction price | USD 2.43 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Spero contract
Based on the Rule 16, the options market is currently suggesting that Spero Therapeutics will have an average daily up or down price movement of about 0.11% per day over the life of the 2026-04-17 option contract. With Spero Therapeutics trading at USD 2.44, that is roughly USD 0.002623 . If you think that the market is fully incorporating Spero Therapeutics' daily price movement you should consider acquiring Spero Therapeutics options at the current volatility level of 1.72%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out Spero Therapeutics Basic Forecasting Models to cross-verify your projections. Spero Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Spero Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Spero Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Spero Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Spero Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Spero Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Spero Therapeutics' historical news coverage. Spero Therapeutics' after-hype downside and upside margins for the prediction period are 0.12 and 5.01, respectively. We have considered Spero Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Spero Therapeutics is relatively risky at this time. Analysis and calculation of next after-hype price of Spero Therapeutics is based on 3 months time horizon.
Spero Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Spero Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Spero Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Spero Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.14 | 2.58 | 0.01 | 0.12 | 9 Events / Month | 7 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
2.44 | 2.43 | 0.41 |
|
Spero Therapeutics Hype Timeline
Spero Therapeutics is at this time traded for 2.44. The entity has historical hype elasticity of -0.01, and average elasticity to hype of competition of -0.12. Spero is projected to decline in value after the next headline, with the price expected to drop to 2.43. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.41%, whereas the daily expected return is at this time at 0.14%. The volatility of related hype on Spero Therapeutics is about 290.54%, with the expected price after the next announcement by competition of 2.32. About 23.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.79. Given the investment horizon of 90 days the next projected press release will be in about 9 days. Check out Spero Therapeutics Basic Forecasting Models to cross-verify your projections.Spero Therapeutics Related Hype Analysis
Having access to credible news sources related to Spero Therapeutics' direct competition is more important than ever and may enhance your ability to predict Spero Therapeutics' future price movements. Getting to know how Spero Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Spero Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| MCRB | Seres Therapeutics | (8.28) | 8 per month | 0.00 | (0.03) | 9.13 | (7.64) | 54.10 | |
| VTGN | VistaGen Therapeutics | (0.01) | 6 per month | 0.00 | (0.12) | 7.93 | (12.80) | 96.59 | |
| ACTU | Actuate Therapeutics Common | 0.28 | 8 per month | 0.00 | (0.13) | 5.40 | (6.74) | 20.01 | |
| INO | Inovio Pharmaceuticals | (0.17) | 9 per month | 0.00 | (0.11) | 6.87 | (6.80) | 36.52 | |
| ABOS | Acumen Pharmaceuticals | 0.14 | 10 per month | 0.00 | (0.04) | 9.18 | (7.18) | 25.06 | |
| SEER | Seer Inc | 0.01 | 8 per month | 0.00 | (0.13) | 3.41 | (3.06) | 9.98 | |
| CGTX | Cognition Therapeutics | (0.14) | 10 per month | 0.00 | (0.05) | 8.89 | (8.38) | 24.96 | |
| IRD | Opus Genetics | (0.07) | 10 per month | 3.51 | 0.1 | 6.70 | (6.10) | 26.50 | |
| HURA | TuHURA Biosciences | (0.05) | 12 per month | 0.00 | (0.24) | 7.73 | (10.53) | 50.34 | |
| CRBP | Corbus Pharmaceuticals Holding | (0.59) | 11 per month | 0.00 | (0.25) | 4.60 | (8.37) | 32.00 |
Spero Therapeutics Additional Predictive Modules
Most predictive techniques to examine Spero price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Spero using various technical indicators. When you analyze Spero charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Spero Therapeutics Predictive Indicators
The successful prediction of Spero Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Spero Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Spero Therapeutics based on analysis of Spero Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Spero Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Spero Therapeutics's related companies. | 2025 | 2026 (projected) | Dividend Yield | 0.003522 | 0.00313 | Price To Sales Ratio | 1.33 | 1.27 |
Pair Trading with Spero Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Spero Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spero Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Spero Stock
| 0.51 | XENE | Xenon Pharmaceuticals | PairCorr |
| 0.48 | AURA | Aura Biosciences | PairCorr |
| 0.4 | RARE | Ultragenyx | PairCorr |
| 0.38 | GALT | Galectin Therapeutics | PairCorr |
| 0.38 | CNTA | Centessa Pharmaceuticals | PairCorr |
The ability to find closely correlated positions to Spero Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Spero Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Spero Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Spero Therapeutics to buy it.
The correlation of Spero Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Spero Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Spero Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Spero Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Spero Therapeutics Basic Forecasting Models to cross-verify your projections. To learn how to invest in Spero Stock, please use our How to Invest in Spero Therapeutics guide.You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Spero Therapeutics. If investors know Spero will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Spero Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.753 | Earnings Share (0.79) | Revenue Per Share | Quarterly Revenue Growth (0.60) | Return On Assets |
The market value of Spero Therapeutics is measured differently than its book value, which is the value of Spero that is recorded on the company's balance sheet. Investors also form their own opinion of Spero Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Spero Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Spero Therapeutics' market value can be influenced by many factors that don't directly affect Spero Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Spero Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Spero Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Spero Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.